Skip to main content
. 2020 Jul 23;10(20):9332–9347. doi: 10.7150/thno.47137

Scheme 1.

Scheme 1

Targeted inhibition of USP7 modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer.